Neurociencias
Departamento
Stanford University
Stanford, Estados UnidosPublicaciones en colaboración con investigadoras/es de Stanford University (11)
2022
-
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort
npj Parkinson's Disease, Vol. 8, Núm. 1
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2020
-
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
The Lancet Neurology, Vol. 19, Núm. 1, pp. 71-80
-
LUZP1, a novel regulator of primary cilia and the actin cytoskeleton, is a contributing factor in townes-brocks syndrome
eLife, Vol. 9, pp. 1-84
2019
-
Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)
Parkinsonism and Related Disorders, Vol. 62, pp. 201-209
2017
2016
-
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Autophagy
-
Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy
Nature Communications, Vol. 7
2011
2009
-
Optogenetic control of epileptiform activity
Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, Núm. 29, pp. 12162-12167
2008
-
Adult neurogenesis, mental health, and mental illness: Hope or hype?
Journal of Neuroscience